Kidney cancer, Renal cell cancer
Results
Phase 2
This study looked at having axitinib before surgery for kidney cancer to help shrink the cancer or stop it growing.
It was open to people:
whose cancer was growing into the major veins of the kidney and
who were having surgery to remove all, or part, of their cancer
People could join the study between 2017 and 2020. The team published the results between 2022 and 2025.
Recruitment start: 1 December 2017
Recruitment end: 31 January 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Mr Grant Stewart
Common Services Agency (CSA)
NHS National Services Scotland
Pfizer
Scottish Clinical Trials Research Unit (SCTRU)
Last reviewed: 03 Jun 2026
CRUK internal database number: 14833
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
